Skip to main content
. 2021 Apr 23;16(4):e0247359. doi: 10.1371/journal.pone.0247359

Table 2. Clinical adverse events according to the neointimal characteristics at 40.0 months after OCT evaluation.

Homogeneous neointima Heterogeneous neointima Layered neointima p-value
n = 207 (54.9%) n = 93 (24.7%) n = 77 (20.4%)
Non-TLR 18 (8.7%) 13 (14.0%) 6 (7.8%) 0.114
Cardiac death 4 (1.9%) 1 (1.1%) 0 (0%) 0.588
Any MI 1 (0.5%) 3 (3.2%) 2 (2.6%) 0.093
TLR 6 (2.9%) 18 (19.4%) 8 (10.4%) <0.001
Any revascularization 22 (10.6%) 28 (30.1%) 10 (13.0%) <0.001

Data are presented as number (%). MI, myocardial infarction; Non-TLR, non-target lesion revascularization; OCT, optical coherence tomography; TLR, target lesion revascularization